Skip to main content
Erschienen in: Herz 3/2020

27.07.2018 | Original articles

The German CPU registry: Comparison of smokers and nonsmokers

verfasst von: Dr. med. D. Bock, Prof. Dr. J. Senges, C. Pohlmann, M. Hochadel, T. Münzel, E. Giannitsis, C. Schmitt, G. Heusch, T. Voigtländer, H. Mudra, B. Schumacher, H. Darius, L. S. Maier, B. Hailer, M. Haude, Prof. Dr. H. Gohlke, Prof. Dr. U. Hink

Erschienen in: Herz | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Chest pain is a major reason for admission to an internal emergency department, and smoking is a well-known risk factor for coronary artery disease (CAD) and acute coronary syndrome (ACS). The aim of this analysis is to illustrate the differences between smokers and nonsmokers presenting to German chest pain units (CPU) in regard to patient characteristics, CAD manifestation, treatment strategy, and prognosis.

Methods

From December 2008 to March 2014, 13,902 patients who had a complete 3‑month follow-up were enrolled in the German CPU registry. The analysis comprised 5796 patients with ACS and documented smoking status.

Results

Of all the patients in the CPU registry, 35.2% were smokers. Compared with nonsmokers, they were 13.5 years younger (58.2 vs. 71.7 years, p < 0.001), predominantly men (77.1% vs. 65.2%, p < 0.001), and were more frequently diagnosed with single-vessel disease (32.1% vs. 25.2%) as well as ST-elevation myocardial infarction (STEMI; 23.8% vs. 15.5%, p < 0.001). Although the Global Registry of Acute Coronary Events (GRACE) Risk Score for hospital mortality was lower in the group of smokers (106.1 vs. 123.3, p < 0.001), we did not observe any differences in CPU death (0.4% vs. 0.4%, p = 0.69) and CPU major adverse cardiac event (MACE) rates (3.8% vs 2.9%, p = 0.073) between the groups. In the 3‑month follow-up, we documented higher mortality rates in the nonsmoker group (1.9% vs. 2.9%, p = 0.035) in correlation with the GRACE Risk Score (80.3 vs. 105.2, p < 0.001). MACE rates were similar during the follow-up (3.1% vs. 4.1%, p = 0.065).

Conclusion

Observations from the German CPU registry demonstrate that smoking is a strong predictor of acute CAD manifestation early in life, especially STEMI. In spite of a lower GRACE Risk Score and fewer comorbidities, smokers had a rate of hospital mortality similar to the older group of nonsmokers.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Post F, Giannitsis E, Darius H et al (2015) Kriterien der Deutschen Gesellschaft für Kardiologie – Herz-und Kreislaufforschung für “Chest Pain Units“. Kardiologe 9(2):171–181 (Update 2015)CrossRef Post F, Giannitsis E, Darius H et al (2015) Kriterien der Deutschen Gesellschaft für Kardiologie – Herz-und Kreislaufforschung für “Chest Pain Units“. Kardiologe 9(2):171–181 (Update 2015)CrossRef
2.
Zurück zum Zitat Perings S, Smetak N, Kelm M et al (2016) Kriterien der Deutschen Gesellschaft für Kardiologie – Herz-und Kreislaufforschung für “Chest Pain Units”. Kardiologe 10(5):301–306 (Update 2016)CrossRef Perings S, Smetak N, Kelm M et al (2016) Kriterien der Deutschen Gesellschaft für Kardiologie – Herz-und Kreislaufforschung für “Chest Pain Units”. Kardiologe 10(5):301–306 (Update 2016)CrossRef
3.
Zurück zum Zitat Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD (2012) Third universal definition of myocardial infarction. Eur Heart J 33:2551–2567CrossRef Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD (2012) Third universal definition of myocardial infarction. Eur Heart J 33:2551–2567CrossRef
4.
Zurück zum Zitat Keller T, Post F, Tzikas S et al (2010) Improved outcome in acute coronary syndrome by establishing a chest pain unit. Clin Res Cardiol 99:149–155CrossRef Keller T, Post F, Tzikas S et al (2010) Improved outcome in acute coronary syndrome by establishing a chest pain unit. Clin Res Cardiol 99:149–155CrossRef
5.
Zurück zum Zitat Kotseva K, Wood D, Baquer DD et al (2015) EUROASPIRE IV: A European Society of Cardiology survey on lifestyle a therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol 23(6):636–648CrossRef Kotseva K, Wood D, Baquer DD et al (2015) EUROASPIRE IV: A European Society of Cardiology survey on lifestyle a therapeutic management of coronary patients from 24 European countries. Eur J Prev Cardiol 23(6):636–648CrossRef
6.
Zurück zum Zitat Jha P, Ramasundarahettige C, Landsman V et al (2013) 21st-century hazards of smoking and benefits of cessation in the united states. N Engl J Med 368:341–350CrossRef Jha P, Ramasundarahettige C, Landsman V et al (2013) 21st-century hazards of smoking and benefits of cessation in the united states. N Engl J Med 368:341–350CrossRef
7.
Zurück zum Zitat Teo KK, Ounpuu S, Hawken S et al (2006) Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 368:647–658CrossRef Teo KK, Ounpuu S, Hawken S et al (2006) Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 368:647–658CrossRef
8.
Zurück zum Zitat Yusuf S, Hawken S, Ôunpuu S et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937–952CrossRef Yusuf S, Hawken S, Ôunpuu S et al (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937–952CrossRef
9.
Zurück zum Zitat Ambrose JA, Barua RS (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43(10):1731–1737CrossRef Ambrose JA, Barua RS (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43(10):1731–1737CrossRef
10.
Zurück zum Zitat Craig WY, Palomaki GE, Haddow JE (1989) Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 298:784–788CrossRef Craig WY, Palomaki GE, Haddow JE (1989) Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 298:784–788CrossRef
11.
Zurück zum Zitat Smith CJ, Fischer TH (2001) Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction. Atherosclerosis 158:257–267CrossRef Smith CJ, Fischer TH (2001) Particulate and vapor phase constituents of cigarette mainstream smoke and risk of myocardial infarction. Atherosclerosis 158:257–267CrossRef
12.
Zurück zum Zitat Piepoli MF, Hoes AW, Agewally S et al (2016) European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 37(29):2315–2381CrossRef Piepoli MF, Hoes AW, Agewally S et al (2016) European guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 37(29):2315–2381CrossRef
13.
Zurück zum Zitat Zhang Y‑J, Iqbal J, van Klaveren D et al (2015) Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG, the SYNTAX Trial at 5‑year follow-up. J Am Coll Cardiol 65(11):1107–1115CrossRef Zhang Y‑J, Iqbal J, van Klaveren D et al (2015) Smoking is associated with adverse clinical outcomes in patients undergoing revascularization with PCI or CABG, the SYNTAX Trial at 5‑year follow-up. J Am Coll Cardiol 65(11):1107–1115CrossRef
14.
Zurück zum Zitat Wilson K, Gibson N, Willan A, Cook D (2000) Effect of smoking cessation on mortality after myocardial infarction meta-analysis of cohort studies. Arch Intern Med 160(7):939–944CrossRef Wilson K, Gibson N, Willan A, Cook D (2000) Effect of smoking cessation on mortality after myocardial infarction meta-analysis of cohort studies. Arch Intern Med 160(7):939–944CrossRef
15.
Zurück zum Zitat Gerber Y, Rosen LJ, Goldbourt U, Benyamini Y, Drory Y (2009) Smoking status and long-term survival after first acute myocardial infarction. J Am Coll Cardiol 54(25):2382–2387CrossRef Gerber Y, Rosen LJ, Goldbourt U, Benyamini Y, Drory Y (2009) Smoking status and long-term survival after first acute myocardial infarction. J Am Coll Cardiol 54(25):2382–2387CrossRef
16.
Zurück zum Zitat Chritchley JA, Capewell S (2003) Mortality risk reduction associated with smoking cessation in patients with coronary heart disease a systematic review. JAMA 290(1):86–97CrossRef Chritchley JA, Capewell S (2003) Mortality risk reduction associated with smoking cessation in patients with coronary heart disease a systematic review. JAMA 290(1):86–97CrossRef
17.
Zurück zum Zitat Mehta RH, Bhatt DL, Steg PG et al (2008) Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry. Eur Heart J 29:3052–3060CrossRef Mehta RH, Bhatt DL, Steg PG et al (2008) Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry. Eur Heart J 29:3052–3060CrossRef
18.
Zurück zum Zitat Teo K, Lear S, Islam S et al (2013) PURE investigators. Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low income countries: the prospective urban rural epidemiology (PURE) study. JAMA 309:1613–1621CrossRef Teo K, Lear S, Islam S et al (2013) PURE investigators. Prevalence of a healthy lifestyle among individuals with cardiovascular disease in high-, middle- and low income countries: the prospective urban rural epidemiology (PURE) study. JAMA 309:1613–1621CrossRef
19.
Zurück zum Zitat Wienbergen H, Gitt A, Senges J (2007) Versorgungsforschung bei akutem Herzinfarkt. Clin Res Cardiol Suppl 2(4):IV1–IV3CrossRef Wienbergen H, Gitt A, Senges J (2007) Versorgungsforschung bei akutem Herzinfarkt. Clin Res Cardiol Suppl 2(4):IV1–IV3CrossRef
Metadaten
Titel
The German CPU registry: Comparison of smokers and nonsmokers
verfasst von
Dr. med. D. Bock
Prof. Dr. J. Senges
C. Pohlmann
M. Hochadel
T. Münzel
E. Giannitsis
C. Schmitt
G. Heusch
T. Voigtländer
H. Mudra
B. Schumacher
H. Darius
L. S. Maier
B. Hailer
M. Haude
Prof. Dr. H. Gohlke
Prof. Dr. U. Hink
Publikationsdatum
27.07.2018
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 3/2020
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-018-4733-z

Weitere Artikel der Ausgabe 3/2020

Herz 3/2020 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.